Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the leading swine pathogens causing tremendous economic loss to the global swine industry due to its virulence, pathogenesis, infectivity and transmissibility. Although formally recognized only two and half decades ago, molecular dating estimation indicates a more ancient evolutionary history, which involved divergence into two genotypes (type 1 and type 2) prior to the 'initial' outbreaks of the late 1980s. Type 2 PRRSV circulates primarily in North America and Asia. The relatively greater availability of sequence data for this genotype from widespread geographical territories has enabled a better understanding of the evolving genotype. However, there are a number of challenges in terms of the vastness of data available and what this indicates in the context of viral diversity. Accordingly, here we revisit the mechanisms by which PRRSV generates variability, describe a means of organizing type 2 diversity captured in voluminous ORF5 sequences in a phylogenetic framework and provide a holistic view of known global type 2 diversity in the same setting. The consequences of the expanding diversity for control measures such as vaccination are discussed, as well as the contribution of modified live vaccines to the circulation of field isolates. We end by highlighting some limitations of current molecular epidemiology studies in relation to inferring PRRSV diversity, and what steps can be taken to overcome these and additionally enable PRRSV sequence data to be informative about viral phenotypic traits such as virulence.
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Recapitulating porcine reproductive and respiratory syndrome (PRRS)
The late 1980s marked the emergence of a 'mystery swine disease' causing reproductive complications in sows and respiratory disease in growing pigs in the USA (Hill, 1990) . In near synchrony, reports began trickling in from swine-rearing countries across Europe about a swine reproductive disease matching clinical presentations seen in North America (Hopper et al., 1992; Plana et al., 1992; Wensvoort et al., 1991) . After ruling out known bacterial and viral pathogens, and after the isolation of a novel virus, the mystery disease was formally recognized as a novel swine illness and named PRRS and the aetiological agent as PRRS virus (PRRSV). The initial lack of knowledge on many aspects of PRRSV biology, including its transmission modes, allowed the virus to quickly spread globally from its original outbreak epicentres in northern Europe, mid-western USA and eastern Canada. Today, far from being eradicated, PRRSV is endemic to virtually all swine-rearing regions and presents substantial challenges in its management.
Despite the commonality of clinical symptoms and timing of emergence, comparative sequence analysis of prototype strains from Europe [Lelystad virus (LV)] and North America (ATCC VR2332) revealed surprisingly significant divergence (Murtaugh et al., 1995; Nelsen et al., 1999) , which was also evident at the antigenic level (Magar et al., 1995; Nelson et al., 1993) . All subsequent isolates characterized to date have been found to cluster with either LV or VR2332, thus establishing two genotypes. The nomenclature for the LV genotypic cluster is type 1 and for the VR2332 genotypic cluster, it is type 2. PRRSV shares similarities with equine arteritis virus (EAV), simian hemorrhagic fever virus and lactate dehydrogenase elevating virus (LDV), all of which now collectively comprise the family Arteriviridae in the order Nidovirales (Conzelmann et al., 1993; Meulenberg et al., 1993) . The evolutionary origin of PRRSV is unknown. Speculation that it is derived from LDV by one or more cross-species transmission events and intercontinental migration via intermediate hosts (Plagemann, 2003) is not supported by evidence of intermediate viral forms, such as PRRSV-or LDV-like isolates in rodents or other Suidae (Shi et al., 2010a) . Once established in swine, the epidemic appearance of PRRSV was associated with large-scale changes in the swine industry and erstwhile global pig movement (Murtaugh et al., 2010) .
In contrast to the uncertain origin of PRRSV, there is unanimity regarding the immense genetic diversity not only among genotypes but within each genotype as well. This genetic variability, whilst a natural survival mechanism from host immune responses, has simultaneously been a primary reason for the inability to develop a vaccine offering broad, solid protection against the PRRS challenge. Hefty economic loss is incurred from PRRSV annually in the USA alone (Holtkamp et al., 2013; Neumann et al., 2005) . As a result, the surveillance and monitoring of PRRSV evolution is fundamental to all stakeholders in the management of PRRS. Here, with a specific focus on type 2 PRRSV, we review the mechanisms that drive PRRSV radiation and a method of organizing and tracking viral diversity using phylogenetics. Additionally, we highlight temporal changes in regional strain diversity and their implications. We close by looking at the shortcomings of current studies of diversity and how next to utilize sequence information beyond simple inter-strain relatedness investigations.
PRRSV: the virus
The PRRSV genome comprises a single, positive-sense, polycistronic RNA strand of approximately 15 kb, which is 39 polyadenylated and presumed to be 59 capped. Aside from two small stretches of UTRs, one at each end of the genome, 10 ORFs have been identified (Fig. 1) . Three-quarters of the genome from the 59 end is occupied by ORF1a and ORF1b, which encode replicative enzymes. Translation of these ORFs produces polyprotein (pp) 1a and pplab, respectively. The latter is expressed by a 21 ribosomal frameshift signal in the overlapping region of the two ORFs, which lengthens pp1a into pp1ab at the C terminus (Snijder & Meulenberg, 1998) . The 39 end of the remaining encoding genome compactly houses eight relatively smaller ORFs encoding structural proteins that are synthesized by the translation of a nested set of subgenomic mRNAs.
Noteworthy is ORF5 due to its extensive use in diversityrelated studies (discussed below).This structural ORF spans 603-606 nt and encodes GP5, which forms a heterodimer with the M protein. This heterodimerization is critical to virus assembly and infectivity in EAV (Snijder et al., 2003) , and a similar role is presumed for PRRSV (Xia et al., 2009) . Selective pressure analysis of ORF5 indicates a varying number of positively selected sites, localized mainly on the N-terminal part and ectodomain of GP5 (Delisle et al., 2012; Storgaard et al., 1999; Xu et al., 2010) , including a known antigenic site (Hanada et al., 2005; Hu et al., 2009) , which probably relates to differing environmental/experimental conditions and sequence datasets among studies.
Molecular mechanisms underlying PRRSV evolution

Replication traits
As is the case with other RNA viruses, PRRSV replication is an error-prone process resulting from the lack of proofreading capability of the viral polymerase. Although no empirical estimate of the mutation rate in PRRSV is presently available, it is widely accepted that RNA viruses display the highest mutation rates of any organism, approximately one mutation per replication (Drake, 1993; Duffy et al., 2008; Sanjuán et al., 2010) . Secondly, replication kinetics enable the production of thousands of viral particles within hours of a single successful infection event. Extrapolating to the individual host level, even by conservative estimates, many millions of viral particles are present at the peak of infection. Such large populations enhance the effectiveness of natural selection wherein novel mutants with increased fitness supersede competitively inferior alleles. In addition, there are a number host cellular enzymes that bolster the viral mutation rate, partly as innate antiviral defence mechanisms in an attempt to push RNA viruses over the tolerable error threshold so that the accumulation of deleterious mutations either reduces fitness or inhibits replication. One pertinent example is porcine APOBEC3 proteins that deaminate cytosine residues to uracil (LaRue et al., 2008) . A more detailed discussion on cellular activities, ORF1b 5′ 3′ Fig. 1 . Genome organization in PRRSV. Two relatively large ORFs (1a and 1b) at the 59 end encode two non-structural polyproteins, pp1a and pp1ab. The latter is produced by lengthening pp1a, which is enabled by a "1 ribosomal frameshift signal (RFS). The 39 end of the genome contains eight structural ORFs followed by a poly(A) tail.
in this respect, possibly impacting on PRRSV replication fidelity is available elsewhere (Murtaugh et al., 2010) .
Quasispecies
The poor fidelity with which RNA viruses replicate inevitably quickly gives rise to a mutational swarm of variants. Very frequently, including for PRRSV (Brar et al., 2014; Goldberg et al., 2003; Rowland et al., 1999) , this intrahost variation is collectively attributed to the quasispecies phenomenon. The quasispecies theory (Eigen & Schuster, 1977) , if formally applied to viruses, mandates that natural selection acts on the mutant swarm as a single unit, envisioning mutational coupling of individual variants, a consequence of the mutation rate bordering the error threshold. By contrast, Darwinian natural selection acts on the individual organism or genome. As evidence of natural selection operating on the population as a unit rather than favouring the 'fittest' variants has not yet been demonstrated under natural conditions (Holmes, 2010) , there is no compelling reason at this time to invoke quasispecies as necessary for PRRSV evolution.
Selection of mutants from the 'swarm' of variants of a singular PRRSV strain is an understudied area and therefore there is a lack of understanding as to the biological significance of this variation in PRRSV. One study sequenced individual ORF5 clones from the tonsils of naturally infected swine. No differences were detected in the rates of synonymous and non-synonymous nucleotide substitution within characterized epitopes and elsewhere, indicating that the observed diversity was not maintained by positive selection for evasion of host immunity (Goldberg et al., 2003) . Similarly, the limited data from cell-culture studies has not shown convincing evidence of variant selection or hotspots (Brar et al., 2014; Lu et al., 2014; Schommer & Kleiboeker, 2006) .
Recombination
Recombination is an integral activity of the PRRSV life cycle enabling the generation of subgenomic mRNAs through discontinuous RNA synthesis of a nested set of subgenomic negative strands serving as transcriptional templates. The process mirrors the 'copy choice' recombination model (Lai, 1992) , in which the RNA-dependent RNA polymerase switches from the donor template to the acceptor template, a process mediated by transcription regulatory sequences in PRRSV, whilst remaining attached to the nascent strand. A similar role is played by recombination in the production of heteroclite RNAs, the functional relevance of which remains to be elucidated, at a scale of comparable prominence to subgenomic mRNAs. The process occurs at variable short stretches of sequence similarity independent of transcription regulatory sequence sites (Yuan et al., 2000 (Yuan et al., , 2004 . In this sense, it would appear that recombination is simply a by-product of the arteriviral transcriptional strategy and a means to control gene expression.
From an evolutionary standpoint, in cases of co-infection with more than one strain, recombination can hasten the pace at which combinations of advantageous mutations are obtained or deleterious mutations are purged. Cell-culture studies have shown that recombination occurred within but not between genotypes in type 1 (van Vugt et al., 2001) and type 2 Yuan et al., 1999) PRRSV. Recombination was also demonstrated in animals Murtaugh et al., 2002) . Recombinant viruses were less fit and did not survive beyond a few passages in competition with the parental strains Yuan et al., 1999) . Although recombinants may be less fit on average, bioinformatic analyses screening for recombination in varying lengths and regions of sequence datasets have revealed the prominent role played by recombination in shaping global PRRSV diversity (Fang et al., 2007; Forsberg et al., 2002; Shi et al., 2013a) . It is not yet known what impact recombination has played in phenotypic evolution, for example related to virulence, host preference or immune escape. As recombination introduces large-scale genetic changes into a genome, it can greatly accelerate evolution compared with single point mutations.
Thus, its role in PRRS may be important due to the appearance of recombinants associated with outbreaks (Shi et al., 2013a) or identified circulating in significant numbers over wide geographical areas originating from common ancestors (Shi et al., 2013b) when in the past only sporadic instances were detected (Li et al., 2009a, b; Yoshii et al., 2008) .
Molecular epidemiology of PRRSV
The abundance of type 2 PRRSV genetic information, primarily in ORF5, is due to a desire to understand PRRSV evolution and its molecular mechanisms, as well as a practical need to determine how outbreaks occur in swine herds for effective management and intervention. Phylogenetic analysis of samples collected over time in a farm or region has proven useful in evaluating the effectiveness of control and prevention strategies, as well as in determining routes of virus transmission. The genetic relationships revealed by phylogenetic analysis provide more robust epidemiological information than is achieved by other methods of viral classification (Murtaugh et al., 2010) . The development of a system in a user-friendly setting performing typing tasks in a time-efficient manner without the need to manually perform individual steps (alignment, recombination screening and phylogeny reconstruction) every time could be a logical and important advancement in future, a prospect that would help standardize diversity or phylogenetic studies on PRRSV, allowing meaningful comparisons across studies.
Phylogenetic classification of type 2 PRRSV
The relatively high sequence variability observed in ORF5 early on (Kapur et al., 1996; Meng et al., 1995) popularized its use in discerning field isolates and epidemiological studies (Goldberg et al., 2000; Mondaca-Fernández et al., 2006) . As a result, to date, the primary source of PRRSV sequence data in public and non-public databases pertains to ORF5. Using approximately 8000 ORF5 sequences obtained from these sources, Shi et al. (2010b) developed a high-resolution phylogenetic classification framework for type 2 PRRSV. The system categorized type 2 isolates into nine well-supported lineages with almost all interlineage genetic distances being greater than 10 %. Assuming that sequence divergence occurred by independent mutations at a constant rate, a number of lineages appeared to have become established before PRRS was recognized in the late 1980s. Later inclusion of additional datasets into the system indicated that all major groups of type 2 PRRSV have been identified (Brar et al., 2011; Kvisgaard et al., 2013; Shi et al., 2013b) .
Type 2 PRRSV diversity dynamics: what's new?
Global analysis of ORF5 sequences revealed important insights into the evolving geographical diversity of PRRSV (Murtaugh et al., 2010; Shi et al., 2010a, b) . Since then, the collection of ORF5 sequences has expanded from approximately 8000 to well over 13 000. The increased richness of sequence variation has enabled further analysis of genetic diversity and its implications.
The stark divergence between type 1 and type 2 PRRSV was recognized early on (Murtaugh et al., 1995; Nelsen et al., 1999) . Later, the extensive diversity within each genotype also became evident (Forsberg et al., 2002; Indik et al., 2000; Kapur et al., 1996; Meng et al., 1995; Stadejek et al., 2002 Stadejek et al., , 2006 . Whilst mutation and recombination are the intrinsic causes of genetic variation, the molecular epidemiology of virus diversity is due to extrinsic factors such as transmission dynamics, swine management practices, vaccination practices and, possibly, pig genetic variation. Local variation in these factors is widespread and will influence regional characteristics of genetic diversity. Accordingly, PRRSV diversity was examined at two levels: global, akin to viewing a forest, and regional, akin to the individual trees in the forest.
Diversity: looking at the 'forest'. Acquisition of sequence data from Canada and Mexico was an important step in better gauging global type 2 diversity, as retrospective serological screening suggests that Canada had the earliest history of type 2 PRRSV circulation (Carman et al., 1995) , whilst significant ORF7 diversity was reported in Mexico (Batista et al., 2004) . Incorporation of all additional sequences occurred within the previously identified nine lineages. Seven of these lineages are still dominated by North American isolates, whilst the remaining two comprise primarily Asian isolates. Based on the topology of the phylogenetic tree and ancestral state reconstruction, it appears that lineages 1 and 2 originated in eastern Canada, whilst lineages 6 to 9 originated in the USA (Shi et al., 2013b) . Global type 2 diversity is dominated mainly by isolates of four lineages (L1, L5, L8 and L9), which collectively constitute over 97 % of all ORF5 sequences (Fig. 2a) . Whilst some lineages remain more or less static in terms of diversity over an extended temporal scale, there are clear instances where longitudinal sample analysis reveals a gradual rise in sequence divergence among field isolates. Such a trend is most apparent in lineages 1 and 9. In these cases, over the past decade to decade and a half, there has been a demonstrable shift in pairwise sequence variability from ¡10 % between isolates to .10 % in more recent times (Fig. 2b) . Similar patterns of change in temporal genetic diversity have been seen previously in a Bayesian phylogenetic framework (Shi et al., 2010b) .
Global type 2 genetic diversity has also been shaped by the use of modified live vaccines that replicate in and transmit among non-immune hosts, allowing for the potential establishment of new, local populations of vaccine-related genotypes and with the possibility of reversion to virulence (Nielsen et al., 2001; Opriessnig et al., 2002) . However, due to the high similarity between vaccine and parental strains, it may be difficult to discern whether closely related isolates are evolved from a vaccine introduction or field virus related to the parental strain of the vaccine. In fact, wild-type and vaccinerelated isolates form a single large monophyletic cluster with poor topological support (posterior probabilities) within the cluster, making phylogenetic delineation difficult as well. Hence, to obtain a crude estimate of live vaccine contribution to global PRRSV diversity, we examined two sublineages, 5.1 (VR2332/RespPRRS MLV) and 8.9 (JA142/ PRRS ATP), in which extensive relevant sequence data are available. Within each sublineage, the genetic distance between the prototype and vaccine strains was determined and used as a cut-off for the subsequent step. Next, field isolates of each sublineage with a divergence from the prototype and/or vaccine being less than the cut-off were extracted (sublineage 5.1: n5451; sublineage 8.9: n5550). Counts for being wild-type or vaccine-related were incremented depending on whether greater similarity was shared with the parental or vaccine strain. Based on the above method, of the isolates analysed, 80 % could be deemed vaccine-related in sublineage 5.1 whilst the same figure would be 60 % for sublineage 8.9. Overall, such vaccineassociated sequences would represent approximately 5 % of global type 2 virus sampling. However, the estimates from the method described here could also be biased as they do not take into account shared-derived substitutions.
Diversity: looking at the 'trees'. Canada and the USA have a high degree of circulating diversity (Fig. 3a) . Canadian diversity is highly skewed, being most pronounced in the eastern provinces and is probably due primarily to radiation in lineage 1 ( Fig. 3b ; Brar et al., 2011) . Diversity in the western provinces of Saskatchewan and Alberta is limited, and the dominant variants are similar to vaccine-related strains (Fig. 3b) USA on the south, harbours strains with a median divergence equivalent to that seen in the USA. However, in contrast to Canada and the USA, Mexico has a set of extremely divergent outliers with pairwise genetic distances greater than 0.2 (Fig. 3a) . Unlike the situation in Canada, PRRSV lineages have been introduced into the USA and Mexico at least once and perhaps more times. The lineage 1 family of viruses that originated in eastern Canada first appeared in the USA in the late 1990s and early 2000s (Brar et al., 2011) . Many, if not all, type 2 PRRSV in Mexico were observed previously in the USA, suggesting multiple introductions. As the total genetic diversity in the USA and Mexico is the same or less than is observed in Canada, virus introductions do not appear to play a significant role in the generation of genetic diversity.
In Europe, it appears that almost all type 2 PRRSV diversity is related to re-isolation of PRRS MLV vaccine progeny since its first use in Denmark in 1996 (Bøtner et al., 1997) . All Danish isolates spanning a period of over a decade are in lineage 5, sublineage 5.1, which contains PRRS MLV (Bøtner et al., 1997; Kvisgaard et al., 2013; Nielsen et al., 2001) . Sparse sequence data from Europe and Russia, primarily in Germany, Lithuania, Poland and Slovakia, shows that independent introduction of virulent field viruses in lineages 1 and 8 has also occurred.
Within Asia, there is a wide spectrum in the variability of isolates within various countries. In pairwise comparisons, China and Vietnam show reduced regional genetic variation due to the rapid spread of highly pathogenic PRRSV (HP-PRRSV) since 2006 and an accompanying explosion of PRRSV sequencing for outbreak isolates (Thuy et al., 2013; Tian et al., 2007; Zhou et al., 2011) . In addition, the high growth rate of these viruses and facile transmissibility appears to have resulted in ecological displacement of previously resident strains, similar to the displacement of resident strains by sublineage 1.7-1.9 (MN184-like) viruses following their introduction into Minnesota, USA, in 2000 (Shi et al., 2013b; J. Torrison and M. P. Murtaugh, unpublished data) . The much larger intra-country divergence among isolates of other Asian nations is due to a higher proportion of non-HP-PRRSV sequences in the dataset, and multiple introductions of North American virus diversity that co-circulate with Asian lineages.
Implications. A primary concern of the ever-expanding genetic diversity of PRRSV is a concomitant expansion of antigenic diversity that renders vaccines ineffective in providing meaningful protection. It has long been recognized that live, attenuated PRRSV vaccines do not provide uniformly complete protection against challenge with divergent isolates in the same type 1 or type 2 genotype (Kimman et al., 2009; Labarque et al., 2004) randomly sampled genetic distances for each time frame are summarized for the two lineages. (c) Widening genetic disparity over time between prominent lineages and commercially available vaccines. Sequences were grouped by collection dates separately for lineages 1, 8 and 9. Pairwise p-distances between field isolates and vaccines (RespPRRS MLV and PRRS ATP) were determined and summarized.
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Genetic distance (a) (b) Fig. 3 . Genetic variability of isolates within major countries and regions impacted by type 2 PRRSV. ORF5 sequences were partitioned based on place of collection. Pairwise p-distances for each partition were determined and a maximum of 10 000 randomly sampled values were summarized as boxplots. Box boundaries represent the first and third quartiles and the division inside the box the median. Whiskers represent at maximum 1.5¾ interquartile range. Open circles outside upper and lower whiskers represent outliers. These findings indicate that some key immunological targets important for protection are conserved despite high levels of genetic and antigenic diversity. Hence, replicating type 2 vaccine strains, which by definition are a population of highly homogeneous sequences, still share critical sequences with essentially all type 2 PRRSVs, even though genetic distances between longitudinally stratified isolates and commercially available vaccines show a pattern of widening divergence over time (Fig. 2c) .
Another issue linked to vaccination is safety. The potential of reversion to virulence by modified live vaccines has been discussed already. Although a conservative estimate of vaccine-associated sequences has been provided here, it is not possible to infer what share might exhibit virulence traits based on sequences of a single ORF and a lack of experimental data as produced elsewhere (Opriessnig et al., 2002) . Presently, attempts are under way to develop vaccines using novel strategies that are safer and provide better protection (Hu & Zhang, 2012; Huang & Meng, 2010) .
Comparisons of pairwise genetic distances between isolates in different regions of Canada (specifically Ontario and Quebec) and the USA revealing similar divergence is an outcome partly reflective of the intensive viral flow between the countries that has already previously been revealed through phylogeographical analyses (Shi et al., 2010b (Shi et al., , 2013b . This work by Shi and colleagues indicates that the continuous viral flow, especially in recent times, is gradually displacing previously endemic USA PRRSVs in the Midwest, Corn Belt, Lake States and Northern Plains with those that originated in Canada. The largely unidirectional cross-border viral flow is supported by patterns of pig movement showing a substantial importation of growing pigs into low-cost feeder sites in the Corn Belt and Lake States (Shields & Mathews, 2003) . Additionally, an intense viral traffic network within the USA (Shi et al., 2013b) enabled by establishment of multisite swine production facilitates the rapid spread of locally emerged or introduced diversity to geographically distant locations. Collectively, this highlights the need for strengthening surveillance to monitor changes in regional viral genetic diversity that are indicators of virus outbreaks in origination sites, as well as new disease threats in destination regions.
Diversity -what are we missing? PRRSV sequencing in North America is performed primarily on samples submitted to veterinary diagnostic laboratories by veterinarians to determine the types of viruses associated with outbreaks. The veterinary diagnostic laboratories are affiliated with public universities, and the sequencing information is generally deposited in GenBank or made available on request. The widespread adoption of diagnostic sequencing, particularly in the USA and Canada, has produced such an abundance of ORF5 sequences that the non-random collection is a moot issue. Except for attenuated vaccine strains, there is no evidence to support the existence of non-pathogenic strains, so random sampling of herds in the absence of PRRS would be pointless. The observation that overall lineage diversity remained the same between 2010 and 2014, despite an additional 5000 sequences in the database, indicates that sampling randomness is not an issue. In addition, diagnostic sequencing has been carried out in the USA for 20 years, beginning in 1994 in the Minnesota Veterinary Diagnostic Laboratory and thereafter in other diagnostic laboratories. Hence, there is a rich historical record of genetic diversity in North America.
PRRSV sequencing in Asia, the other type 2 PRRSV hotspot, is performed largely in academic laboratories or in private swine companies, and on a large scale only after HP-PRRSV appeared in 2006. Fig. 3 (a) also suggests that genetic diversity is underestimated in China. Hong Kong, Taiwan, Japan, South Korea and Thailand show levels of genetic variation equivalent to North American countries. Hong Kong diversity is particularly interesting as it does not have an indigenous swine industry and imports pigs from China. In addition, sequencing records from Chinese production companies show the presence of numerous lineages and genetic diversity in recent years (M. P. Murtaugh, personal observations). Thus, it is possible that the genetic population structure of PRRSV in Asia is incompletely represented at this time.
The characterization of type 2 PRRSV genetic diversity is a description of ORF5 genetic variation. Concentration on this variable 600 nt sequence has resulted in a large database that has yielded many insights into the evolution of PRRSV. Direct comparison to the polymerase region and ORF7 showed that it provided more data on sequence variation (Chang et al., 2002) . As it constitutes only about 4 % of total genomic information, its analysis gives only limited insights into the contribution of recombination to the generation of genetic diversity. Inaccurate inferences of strain relatedness are also possible if recombination breakpoints lie outside a small studied genomic region that belongs to the minor parent only.
The increasing availability of high-throughput sequencing is expanding the amount of whole-genome PRRSV information in GenBank. At present, about 300 whole-genome sequences have been deposited and the number is certain to increase rapidly. Thus, we look forward to a more comprehensive assessment of genomic diversity and evolution that incorporates all of the heritable information in PRRSV and provides deeper insights into the roles of mutation and recombination in driving virus evolution within individual swine hosts as well as in host populations (Brar et al., 2014; Guo et al., 2011; Kvisgaard et al., 2013; Lu et al., 2014) . Presently, however, no comprehensive work characterizing the evolutionary dynamics of globally sampled PRRSV isolates, as in the case of ORF5, using whole-genome data exists aside from a recent study investigating virus recombination (Martín-Valls et al., 2014) .
Beyond PRRSV diversity
Sequence information on genetic diversity by itself does not inform us about fundamental questions of PRRSV virulence, pathogenesis and immunity that are central to disease control and virus elimination. To accomplish this goal, it is essential to connect phenotypic metadata with sequence information. To explore the current status of sequence metadata, we downloaded all non-patent nucleotide submissions pertaining to PRRSV in GenBank (the largest public repository of PRRSV sequences as of April 2014). A total of 16 143 sequences (UTRs, ORFs and partial and complete genomes) were obtained. Of these, 16 % lacked any information on country or region of isolation and 22 % did not have any indication of isolation date, not even a year. Next, the proportion of sequence data with associated phenotypic information was ascertained by identifying GenBank submissions linked to published articles. This accounted for only 25 % of all submissions, the majority of which consisted of sequence analysis of ORFs or complete genomes that were largely devoid of phenotypic traits of the reported isolates or used subjective descriptors like 'highly pathogenic' or 'moderately pathogenic' without any qualifying statements on quantitative measures of morbidity, mortality or immunological reactivity.
Publications that linked genotype and phenotype were a minor component of GenBank accessions (Brockmeier et al., 2012; Darwich et al., 2011; Díaz et al., 2006; Gauger et al., 2012; Kim et al., 2007; Lee et al., 2004; Li et al., 2010; Martínez-Lobo et al., 2011a, b; Yu et al., 2013) . Moreover, as the phenotypes examined can vary among genotype/ phenotype studies, comparisons between isolates can still be cumbersome and ambiguous. Progress in elucidating genetic determinants of important phenotypic characteristics such as virulence, immunological reactivity and clinical presentation would be assisted by the development of a public database including PRRSV sequences along with pertinent phenotypic metadata. Such a resource would enable the design of more-focused experiments involving chimeric infectious clones and/or site-directed mutagenesis to examine regions of difference potentially linked to phenotypic outcomes and not just the result of genetic drift and/or random mutation.
Concluding remarks
Whether the evolutionary emergence of PRRSV as a novel swine disease occurred by cross-species transmission or other means will never be known with certainty. However, the study of PRRS over the past two and a half decades has revealed the hand of humans in the establishment, expansion in diversity and geographical spread of PRRSV through the development of modern management practices, artificial breeding practices, extensive transportation, international trade in live animals and germplasm, and vaccination practices, which, in one way or another, have proved advantageous to the intrinsic ability of PRRSV to generate and promulgate diversification. In order for production management and disease control strategies to keep pace with a rapidly evolving virus, access to publicly available high-resolution phylogenetic knowledge linked to phenotypic information will be a valuable asset. Such resources could help bridge the gap between known and actual diversity as well as inform the design of studies that link variation in PRRSV genomes to variation in key phenotypic characteristics.
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